QBIOGENE ANNOUNCES STRATEGIC PARTNERSHIP WITH MOLECULAR SENSING

Qbiogene Inc. (www.qbiogene.com) announces a strategic partnership with Molecular Sensing plc ("Molecular Sensing" or "MSL") to produce an integrated solution for DNA diagnostics. This system will combine MSL's rapid DNA amplification and detection system genedrive? with Qbiogene's industry standard GENECLEAN^® Nucleic Acid Purification Chemistries to produce a disposable device suitable for clinical diagnostics, including near patient testing.

Ben Cobb, Molecular Sensing's CEO, stated that "looking beyond the current genome discovery race, there will be a need to take DNA testing into the wider healthcare market. To do this, DNA extraction and detection technologies will have to be combined onto a single disposable device. This will have to be achieved at low cost and high volume. I believe that Qbiogene's industry standard extraction technologies and know how can be coupled with MSL's rapid detection technology to provide fully-integrated, cost effective solutions for DNA testing."

Qbiogene's CEO Garth Cumberlidge added that "the integration of nucleic acid extraction using the BIO101 brand GENECLEAN^® Technology with MSL's novel PCR detection systems establishes a new platform for DNA detection and quantification. It offers a unique combination of speed, sensitivity, specificity and efficiency to a broad range of potential applications."

Products utilizing the combined technologies are expected to be available within a two-year timeframe.

For more information, contact investor relations.